10-13 Mars 2005 / Aussois, France Effects of restricted feeding time during rest period on tumor progression. Fujii Y., Carrière J., Innominato P., Iurisci I., Karaboué A., Smaaland R., Li X.M., Filipski E., Shimada H., Lévi F. Rôle du moment du pic d’une perfusion chronomodulée de chimiothérapie sur sa toxicité chez des patients atteints de…
lire la suite
June 1-5th, 2005 / Antalya, Turkey
June 1-5th, 2005 / Antalya, Turkey Prolonged monitoring of rest-activity rhythm for assessing chemotherapy effects on circadian system. Iurisci I., Beau J., Karaboué A., Giacchetti S., Innominato P., Carnino S., Laskowski P., Richard S., Iacobelli S., Jasmin C., Lévi F.
lire la suite
Sept 16-21st, 2006 / Montreal, Canada
Sept 16-21st, 2006 / Montreal, Canada Immunohistochemistry and fluorescent in situ hybridization for Epidermal Growth Factor Receptor in metastatic colorectal carcinomas are not predictive for response to chronomodulated chemotherapy combined with cetuximab. Bralet M.P., Herelle O., Bouchahda M., Karaboué A., Schoevaert D., Levi F., Guettier C.
lire la suite
October 16-18th, 2008 / Torino, Italy
October 16-18th, 2008 / Torino, Italy Rest-activity rhythm, a biomarker of the circadian timing system that predicts for toxicity and survival outcomes in cancer patients. Parganiha A., Waterhouse J., Karaboué A., Innominato P., Poncet A., Iurisci I., Giacchetti S., Moreau T., Lévi F.
lire la suite